Terms: = Lymphoma AND MSH2, COCA1, 4436, ENSG00000095002, HNPCC, FCC1, HNPCC1, P43246
99 results:
1. [Pan-cancer analysis of ubiquitin-specific protease 7 and its expression changes in the carcinogenesis of scar ulcer].
Zhang SY; Ruan JJ; Jin DM; Chen N; Xie WG; Ruan QF
Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2023 Jun; 39(6):518-526. PubMed ID: 37805766
[No Abstract] [Full Text] [Related]
2. Constitutional Mismatch Repair Deficiency Syndrome as a Cause of Numerous Malignancies in a Teenage Patient-A Case Report.
Samborska M; Galli D; Achkar R; Thambyrajah S; Derwich K
J Pediatr Hematol Oncol; 2023 Oct; 45(7):e917-e920. PubMed ID: 37526375
[TBL] [Abstract] [Full Text] [Related]
3. Undifferentiated component of dedifferentiated endometrial carcinoma presenting as a "small round cell" malignancy in a mediastinal lymph node, mimicking small cell carcinoma.
Balikani L; Policarpio-Nicolas MLC
Diagn Cytopathol; 2023 Aug; 51(8):519-524. PubMed ID: 37318779
[TBL] [Abstract] [Full Text] [Related]
4. HTLV-1 bZIP factor impairs DNA mismatch repair system.
Sakurada-Aono M; Sakamoto T; Kobayashi M; Takiuchi Y; Iwai F; Tada K; Sasanuma H; Hirabayashi S; Murakawa Y; Shirakawa K; Sakamoto C; Shindo K; Yasunaga JI; Matsuoka M; Pommier Y; Takeda S; Takaori-Kondo A
Biochem Biophys Res Commun; 2023 May; 657():43-49. PubMed ID: 36972660
[TBL] [Abstract] [Full Text] [Related]
5. Genomics improves risk stratification of adults with T-cell acute lymphoblastic leukemia enrolled in measurable residual disease-oriented trials.
González-Gil C; Morgades M; Lopes T; Fuster-Tormo F; García-Chica J; Zhao R; Montesinos P; Torrent A; Diaz-Beya M; Coll R; Hermosín L; Mercadal S; González-Campos J; Zamora L; Artola T; Vall-Llovera F; Tormo M; Gil-Cortés C; Barba P; Novo A; Ribera J; Bernal T; De Ugarriza PL; Queipo MP; Martínez-Sánchez P; Giménez A; González-Martínez T; Cladera A; Cervera J; Fernández-Martín R; Ardaiz MÁ; Vidal MJ; Baena Á; López-Bigas N; Bigas A; Maciejewski J; Orfao A; Ribera JM; Genescà E
Haematologica; 2023 Apr; 108(4):969-980. PubMed ID: 36325893
[TBL] [Abstract] [Full Text] [Related]
6. Molecular markers related to patient outcome in patients with IDH-mutant astrocytomas grade 2 to 4: A systematic review.
Tesileanu CMS; Vallentgoed WR; French PJ; van den Bent MJ
Eur J Cancer; 2022 Nov; 175():214-223. PubMed ID: 36152406
[TBL] [Abstract] [Full Text] [Related]
7. Looking beyond the cytogenetics in haematological malignancies: decoding the role of tandem repeats in DNA repair genes.
Bhattacharya P; Patel TN
Mol Biol Rep; 2022 Nov; 49(11):10293-10305. PubMed ID: 36097110
[TBL] [Abstract] [Full Text] [Related]
8. Adiponectin and Its Effects on Acute Leukemia Cells: An Experimental and Bioinformatics Approach.
Tsartsalis AN; Tagka A; Kotoulas A; Mirkopoulou D; Geronikolou SA; G L
Adv Exp Med Biol; 2021; 1338():117-127. PubMed ID: 34973016
[TBL] [Abstract] [Full Text] [Related]
9. Eruptive nevi in a patient with constitutional mismatch repair deficiency (CMMRD).
Vassantachart JM; Zacher NC; Teng JMC
Pediatr Dermatol; 2022 Jan; 39(1):91-93. PubMed ID: 34787334
[TBL] [Abstract] [Full Text] [Related]
10. A novel Lynch syndrome pedigree bearing germ-line msh2 missense mutation c.1808A>T (Asp603Val).
Sekine R; Shimazu K; Nakano D; Yamaguchi T; Suzuki Y; Fukuda K; Yoshida T; Taguchi D; Iijima K; Nanjyo H; Shibata H
Jpn J Clin Oncol; 2022 Jan; 52(1):81-85. PubMed ID: 34761252
[TBL] [Abstract] [Full Text] [Related]
11. Double heterozygotes of BRCA1/BRCA2 and mismatch repair gene pathogenic variants: case series and clinical implications.
Laish I; Friedman E; Levi-Reznick G; Kedar I; Katz L; Levi Z; Halpern N; Parnasa S; Abu-Shatya A; Half E; Goldberg Y
Breast Cancer Res Treat; 2021 Aug; 188(3):685-694. PubMed ID: 34086170
[TBL] [Abstract] [Full Text] [Related]
12. Clinicopathological features and risk factors for developing colorectal neoplasia in Hodgkin's lymphoma survivors.
Ykema BLM; Rigter LS; Spaander MCW; Moons LMG; Bisseling TM; Aleman BMP; Dekker E; Verbeek WHM; Kuipers EJ; de Boer JP; Lugtenburg PJ; Janus CPM; Petersen EJ; Roesink JM; van der Maazen RWM; Meijer GA; Schaapveld M; van Leeuwen FE; Carvalho B; Snaebjornsson P; van Leerdam ME
Dig Endosc; 2022 Jan; 34(1):163-170. PubMed ID: 33928678
[TBL] [Abstract] [Full Text] [Related]
13. Germline variants of DNA repair genes in early onset mantle cell lymphoma.
Wang X; Song Y; Chen W; Ding N; Liu W; Xie Y; Wang Y; Zhu J; Zeng C
Oncogene; 2021 Jan; 40(3):551-563. PubMed ID: 33191405
[TBL] [Abstract] [Full Text] [Related]
14. Circulating miR-15b, miR-34a and miR-218 as promising novel early low-invasive biomarkers of cervical carcinogenesis.
Ocadiz-Delgado R; Lizcano-Meneses S; Trejo-Vazquez JA; Conde-Perezprina JC; Garrido-Palmas F; Alvarez-Rios E; García-Villa E; Ruiz G; Illades-Aguiar B; Leyva-Vázquez MA; García-Carrancá A; Gariglio P
APMIS; 2021 Feb; 129(2):70-79. PubMed ID: 33112434
[TBL] [Abstract] [Full Text] [Related]
15. Microsatellite instability and its associations with the clinicopathologic characteristics of diffuse large B-cell lymphoma.
Tian T; Li J; Xue T; Yu B; Li X; Zhou X
Cancer Med; 2020 Apr; 9(7):2330-2342. PubMed ID: 32022486
[TBL] [Abstract] [Full Text] [Related]
16. Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia.
Li B; Brady SW; Ma X; Shen S; Zhang Y; Li Y; Szlachta K; Dong L; Liu Y; Yang F; Wang N; Flasch DA; Myers MA; Mulder HL; Ding L; Liu Y; Tian L; Hagiwara K; Xu K; Zhou X; Sioson E; Wang T; Yang L; Zhao J; Zhang H; Shao Y; Sun H; Sun L; Cai J; Sun HY; Lin TN; Du L; Li H; Rusch M; Edmonson MN; Easton J; Zhu X; Zhang J; Cheng C; Raphael BJ; Tang J; Downing JR; Alexandrov LB; Zhou BS; Pui CH; Yang JJ; Zhang J
Blood; 2020 Jan; 135(1):41-55. PubMed ID: 31697823
[TBL] [Abstract] [Full Text] [Related]
17. Comprehensive analysis of PD-L1 expression, HER2 amplification, ALK/EML4 fusion, and mismatch repair deficiency as putative predictive and prognostic factors in ovarian carcinoma.
Schmoeckel E; Hofmann S; Fromberger D; Rottmann M; Luthardt B; Burges A; Jeschke U; Kirchner T; Lax SF; Mayr D
Virchows Arch; 2019 May; 474(5):599-608. PubMed ID: 30734108
[TBL] [Abstract] [Full Text] [Related]
18. [Constitutional MMR deficiency: Genetic bases and clinical implications].
Buecher B; Le Mentec M; Doz F; Bourdeaut F; Gauthier-Villars M; Stoppa-Lyonnet D; Colas C
Bull Cancer; 2019 Feb; 106(2):162-172. PubMed ID: 30551794
[TBL] [Abstract] [Full Text] [Related]
19. Decreased expression of chromodomain helicase DNA-binding protein 9 is a novel independent prognostic biomarker for colorectal cancer.
Xu L; Peng H; Huang XX; Xia YB; Hu KF; Zhang ZM
Braz J Med Biol Res; 2018 Jul; 51(9):e7588. PubMed ID: 30043858
[TBL] [Abstract] [Full Text] [Related]
20. Cancer prevention by aspirin in children with Constitutional Mismatch Repair Deficiency (CMMRD).
Leenders EKSM; Westdorp H; Brüggemann RJ; Loeffen J; Kratz C; Burn J; Hoogerbrugge N; Jongmans MCJ
Eur J Hum Genet; 2018 Oct; 26(10):1417-1423. PubMed ID: 29904176
[TBL] [Abstract] [Full Text] [Related]
[Next]
